http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19990077342-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-80 |
| filingDate | 1997-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1999-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-19990077342-A |
| titleOfInvention | Pyridinecarboxylic acid amide derivative |
| abstract | N- (12-nitrododecyl) -6- (4-ethyl or isopropyl-1-piperazinyl) pyridine-3-carboxamide or a physiologically acceptable salt thereof.n n n The compound has excellent effects on inhibiting cerebral edema, in particular ischemic brain edema, and inhibitory action on late neuronal cell death (inhibiting Ca inflow into neurons). Since cerebral edema is a condition associated with cerebrovascular disorders, especially in the acute phase of cerebrovascular disorders, the compound is useful as an agent for treating brain edema or cerebrovascular disorder. In addition, the compound is particularly excellent as a therapeutic agent for cerebrovascular injury acute phase, because there is almost no behavioral inhibitory action that is considered to be a side effect in the treatment of cerebrovascular disorder acute phase. In addition, the compound has a brain protective action (anti-anochycia action), an increase in cerebral blood flow, and a lipid peroxidation inhibitory action, and these actions further increase the usefulness as a therapeutic agent for cerebrovascular disorders. |
| priorityDate | 1996-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 143.